• Users Online: 344
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Contacts Login 
Year : 2013  |  Volume : 5  |  Issue : 5  |  Page : 254-260

Management of venous thrombo-embolism: From leeches to novel oral anticoagulants

Division of Internal Medicine, Institute of Medicine, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates

Correspondence Address:
Bisher Oscar Mustafa
Division of Internal Medicine, Institute of Medicine, Sheikh Khalifa Medical City, Abu Dhabi
United Arab Emirates
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1947-489X.210554

Rights and Permissions

Venous thromboembolism (VTE) is one of the three major cardiovascular causes of death, but the history of venous thrombosis in miniature illustrates the development of medicine itself. Anticoagulation therapy has a long history. It started with leeches and passed through heparin, warfarin and low molecular weight heparin (LMWH). The development of the novel oral anticoagulants (NOACs) has marked the beginning of a new era in the treatment of VTE. Dabigatran, Rivaroxaban and Apixaban has been approved for different indications of anticoagulation which include non valvualr atrial fibrillation, venous thromboembolism prophylaxis and treatment. Use of these agents requires expertise in managing the dose and their adjustment in special cases like renal insufficiency as these agents carry risk of bleeding and proper antidote is still being developed. Knowledge of NOACs is essential for all medical personal as these agents are the future of the anticoagulation and they are set to replace warfarin and LMWH on the long term.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded121    
    Comments [Add]    

Recommend this journal